Anakinra

MedicationExperimental1 review

Average score out of 5

Based on 1 experience(s)

Experimental — This treatment is under research. Available data is limited. Consult your doctor before making any decision.

Immunosuppressive drug that blocks interleukin-1 (IL-1), a pro-inflammatory cytokine. It is being investigated in Long COVID for its potential to reduce neuroinflammation and systemic inflammation.

Information

Subcategory: interleukin-1 receptor antagonist
Evidence level: 2/5
Evidence type: small clinical trials and case series

Score distribution

1 (100%)

0 (0%)

Negative

0 (0%)

Latest reviews

Anonymous review+5

36-45 y.o. · 5/2/2026

Share your experience

Your feedback helps thousands of people find what really works.

Join the community